Search

Your search keyword '"Drug-Related Side Effects and Adverse Reactions drug therapy"' showing total 543 results

Search Constraints

Start Over You searched for: Descriptor "Drug-Related Side Effects and Adverse Reactions drug therapy" Remove constraint Descriptor: "Drug-Related Side Effects and Adverse Reactions drug therapy"
543 results on '"Drug-Related Side Effects and Adverse Reactions drug therapy"'

Search Results

101. Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options.

102. What we know and what we don't know about the perioperative use of methadone in children and adolescents.

103. Implementation of a pharmacist toxicology service on treatment of paracetamol (acetaminophen) overdose.

104. Implications of Under-Reporting Medication Side Effects: Beta-Blockers in Heart Failure as a Case Example.

105. The safety profile of EGFR/ALK-TKIs administered immediately before or after ICIs in advanced NSCLC.

106. [Factors associated with adherence to pharmacological treatment of attention deficit hyperactivity disorder (ADHD): preliminary review].

107. Varenicline-induced drug eruption: case and review of the literature.

108. Impact of adverse drug reactions on the outcomes of tuberculosis treatment.

109. Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges.

110. Dietary habits of psoriatic patients treated with dimethyl fumarate and drug-related side effects: results from an observational study.

111. Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis.

112. Adverse drug reactions in children and adolescents on daily antitubercular regimen: An observational longitudinal study.

113. Prevalence and factors associated with drug therapy problems among hypertensive patients at hypertension clinic of Mbarara Regional Referral Hospital, Uganda: a |cross-sectional study.

114. Adverse reactions of Niaoduqing granules: A systematic review and meta-analysis.

115. Erythropoietin as a treatment option for indirect traumatic optic neuropathy: A pilot study.

116. Therapeutic Appropriateness of Cariprazine in the Management of Schizophrenia: Experts' Opinion using a Delphi Approach.

117. Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study.

118. Performance of the paracetamol-aminotransferase multiplication product in risk stratification after paracetamol (acetaminophen) poisoning: a systematic review and meta-analysis.

119. Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency.

120. Clozapine research from India: A systematic review.

121. Side Effects of Antihypertensives Induced by Switching to Different Generic Medications: Case Reports.

122. Losartan-Induced Angioedema with Acute Hypoxemic Respiratory Failure (Anaphylaxis): A Case Report.

123. Cancer immunotherapy and the management of side effects.

124. Effect of Information Intervention on Prescribing Practice for Neuropathic Pain in Older Patients: A Nationwide Register-Based Study.

125. Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease.

126. Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring.

127. [Adverse drug reactions to multiple antibiotics].

128. Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction.

129. Opioid-related adverse drug reactions in patients visiting the emergency division of a tertiary hospital.

130. Post marketing new adverse effects of oral therapies in multiple sclerosis: A systematic review.

131. Efficacy and safety of JAK inhibitors in the treatment of alopecia areata in children: a systematic review and meta-analysis.

132. Plain language summary of the VOLTAIRE-CD study in people with moderate-to-severe active Crohn's disease.

133. Diphenhydramine: Time to Move on?

134. [Ophtalmological adverse events related to immune checkpoint inhibitors].

135. Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring.

136. Urticaria, angioedema, and type I hypersensitivity reactions associated with fibrinolytic agents.

137. Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis.

138. Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data.

139. Prescribing Cascades: How to Detect Them, Prevent Them, and Use Them Appropriately.

140. Sex differences in side effects of antiseizure medications in pediatric patients with epilepsy: A systematic review.

141. Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy.

142. Rapid infusion of infliximab biosimilars and the incidence and severity of infusion-related reactions in patients with inflammatory bowel disease.

143. Antihypertensive Deprescribing in Older Adults: a Practical Guide.

144. Venetoclax-induced vitiligo in a patient with chronic lymphocytic leukemia.

145. Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes.

146. Introducing a simple and cost-effective RT-PCR protocol for detection of DPYD*2A polymorphism: the first study in Kurdish population.

147. Pyridoxine for treatment of levetiracetam-induced behavioral adverse events: A randomized double-blind placebo-controlled trial.

148. Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series.

149. The use of oral vitamin A in acne management: a review.

150. Management of tuberculosis infection in Victorian children: A retrospective clinical audit of factors affecting treatment completion.

Catalog

Books, media, physical & digital resources